How Should Initial Energy Dosing Be Determined By Body Location In Laser Vitiligo Treatment? Optimize Fluence For Each Site

Initial energy dosing should be selected by anatomical location, with higher starting fluences for thicker or less responsive skin. For targeted dermatological laser treatment of vitiligo, typical starting doses range from 100 mJ/cm² around the eyes to 600 mJ/cm² on the fingers and toes. The objective is to produce mild, controlled erythema without blistering, severe discomfort, or prolonged inflammation.

Start with the location-specific fluence, then adjust according to the skin response. Sensitive and highly responsive areas require lower doses; acral and bony areas generally require higher doses.

Why Body Location Determines the Starting Dose

Skin responsiveness varies by region

Vitiligo does not respond uniformly across the body. Facial, scalp, and neck lesions generally respond more readily, while hands, feet, fingers, toes, elbows, and knees are often more resistant.

Thickness and anatomy affect energy delivery

Skin thickness, vascularity, follicular density, and the presence of bony prominences influence how laser energy is absorbed and tolerated. A single fluence for every treatment site can therefore under-treat resistant areas or over-treat delicate ones.

Location is more useful than normal-skin MED testing

For targeted vitiligo treatment, initial dosing should not be based solely on the Minimal Erythema Dose of surrounding normal skin. The lesion’s anatomical location and its clinical response should guide the starting point and subsequent titration.

Recommended Initial Fluences by Location

Delicate and highly responsive areas

Treatment site	Suggested initial fluence
Periocular region	100 mJ/cm²
Face, scalp, ear, neck, axilla, and bikini area	150 mJ/cm²

These regions generally require the lowest starting doses because they are more responsive and may be more sensitive to discomfort or inflammation.

Intermediate-response areas

Treatment site	Suggested initial fluence
Arms, legs, and trunk	200 mJ/cm²
Wrists	250 mJ/cm²
Elbows	300 mJ/cm²
Knees	350 mJ/cm²

Dosing increases as treatment moves toward resistant or bony areas. Elbows, knees, and wrists may need more energy than nearby soft tissue.

Resistant acral areas

Treatment site	Suggested initial fluence
Hands and feet	400 mJ/cm²
Fingers and toes	600 mJ/cm²

Hands, feet, fingers, and toes are commonly among the least responsive sites. Their higher starting fluences should still be applied within the device’s validated clinical protocol and adjusted according to the observed reaction.

How to Adjust the Dose After Treatment

Use mild erythema as the treatment endpoint

The desired initial response is mild, localized erythema. This indicates that the tissue has received a biologically active dose without clear evidence of excessive injury.

Absence of erythema does not automatically justify a large increase. The operator should assess the response at the appropriate interval and account for the treatment schedule and device protocol.

Increase gradually when there is no response

For treatments performed two to three times weekly, a commonly described adjustment is an increase of 50 mJ/cm² per session when no clinical effect or erythema is observed.

The increase should be applied cautiously, especially near the eyes, on thin skin, or in patients with heightened sensitivity.

Reduce the fluence when erythema is excessive

If moderate erythema occurs, reduce the fluence by approximately 50 mJ/cm². If severe erythema develops, treatment should be postponed or the fluence reduced by approximately 100 mJ/cm², depending on clinical assessment.

Blistering, marked pain, crusting, or other signs of tissue injury require stopping treatment and reassessing the protocol before further exposure.

Factors That Refine Location-Based Dosing

Consider the lesion itself

Completely depigmented lesions may require relatively low initial doses, often around 100 to 150 mJ/cm², even when the surrounding skin is darker. The dose should be based on the lesion and its location rather than simply matching the patient’s overall skin phototype.

Protect surrounding healthy skin

Targeted spot delivery and UV-protective templates can limit exposure of normally pigmented skin. This is particularly important when treating sharply localized lesions or anatomically sensitive regions.

Match dosing to the treatment goal

Localized disease is more suitable for targeted treatment than extensive involvement. Patient selection, disease distribution, lesion location, and the response over successive sessions all affect whether the initial fluence remains appropriate.

Understanding the Trade-offs

Higher fluence may improve resistant-site treatment

Increasing energy can help address the lower responsiveness of acral and bony areas. However, the same increase raises the risk of excessive erythema, pain, blistering, and post-inflammatory pigmentary change.

Lower fluence improves tolerance but may delay response

Conservative dosing is appropriate for delicate areas and for patients with a history of strong reactions. The trade-off is that insufficient fluence may produce little clinical effect and prolong the course of treatment.

Location-based tables are starting points, not guarantees

Anatomical recommendations provide a structured initial dose, but they do not replace clinical observation. Device wavelength, spot size, calibration, lesion characteristics, treatment frequency, and patient response must also be considered.

How to Apply This to Your Project

The location-specific values should be treated as clinician-directed starting points within the laser manufacturer’s validated protocol.

If your primary focus is protecting sensitive skin: Start at the lower location-specific fluence, particularly 100 mJ/cm² for periocular skin and 150 mJ/cm² for the face, scalp, ear, neck, axilla, and bikini area, then titrate conservatively.
If your primary focus is treating resistant sites: Use higher starting values for the wrists, elbows, knees, hands, feet, fingers, and toes, reaching 600 mJ/cm² for fingers and toes only with careful monitoring.
If your primary focus is achieving a controlled biological response: Adjust in approximately 50 mJ/cm² increments until mild erythema occurs, reducing or postponing treatment when erythema is moderate or severe.
If your primary focus is minimizing exposure to normal skin: Use targeted delivery and appropriate shielding, and base dosing on the depigmented lesion’s location and response rather than normal-skin MED alone.

The safest dosing strategy combines anatomical starting values with gradual, response-guided adjustment by a qualified clinician.

Summary Table:

Location	Starting Fluence
Periocular	100 mJ/cm²
Face, scalp, ear, neck, axilla, bikini	150 mJ/cm²
Arms, legs, trunk	200 mJ/cm²
Wrists	250 mJ/cm²
Elbows	300 mJ/cm²
Knees	350 mJ/cm²
Hands, feet	400 mJ/cm²
Fingers, toes	600 mJ/cm²

For clinics and premium salons seeking advanced laser solutions for vitiligo and other dermatological conditions, BELIS offers professional-grade medical aesthetic equipment with validated protocols. Our portfolio includes Q-switched Nd:YAG, Pico, and IPL systems designed for effective and safe vitiligo treatment. Contact us today to learn how our technology can enhance your practice and patient outcomes. Contact us.